An Initial Investigation of the Potential of Robusta Coffee, Arabica Coffee, and Caffeine in Asthma Treatment through the Evaluation of 5-Lipoxygenase Inhibition Activity
DOI:
https://doi.org/10.33084/bjop.v7i1.4448Keywords:
Asthma, Coffee, Inflammation, Lipoxygenase, LOX, RobustaAbstract
Numerous studies have documented the potential of coffee to aid in asthma prevention. Nevertheless, research into how coffee influences asthma management has not been available. One known mechanism by which asthma medications work involves inhibiting 5-lipoxygenase (5-LOX) activity. This study aims to determine the potency of Coffea canephora var. Robusta extract (CRE), Coffea arabica extract (CAE), and caffeine are the primary isolates against 5-LOX activity. Extraction was performed by a reflux procedure using 96% ethanol with a sample-total solvent ratio of 1 : 10, an extraction time of 1 hour, and the extraction was conducted in triplicate. Fractionation was carried out by liquid-liquid partition using a chloroform-water system. Caffeine further purification was performed by the sublimation method, and the inhibition of 5-LOX activity was evaluated using the spectrophotometric method at λ = 234 nm. Apigenin was used as a positive control. From the experiment conducted, the IC50 of the CRE, CAE, caffeine, and apigenin against 5-LOX was 32.2 ± 1.4, 42.1 ± 2.3, 14.3 ± 1.6, and 7.4 ± 1.7 µg/mL, respectively. Continued efforts to isolate bioactive compounds from coffee extract led to the discovery of caffeine, which exhibited a more potent inhibitory effect on 5-LOX. The inhibition of 5-LOX activity by caffeine occurs in a non-competitive manner.
Downloads
References
Song P, Adeloye D, Salim H, Dos Santos JP, Campbell H, Sheikh A, et al. Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modelling study. J Glob Health. 2022;12:04052. DOI: 10.7189/jogh.12.04052; PMCID: PMC9239324; PMID: 35765786
Habib N, Pasha MA, Tang DD. Current Understanding of Asthma Pathogenesis and Biomarkers. Cells. 2022;11(17):2764. DOI: 10.3390/cells11172764; PMCID: PMC9454904; PMID: 36078171
Ayola-Serrano NC, Roy N, Fathah Z, Anwar MM, Singh B, Ammar N, et al. The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications. Inflamm Res. 2021;70(8):877-89. DOI: 10.1007/s00011-021-01473-y; PMCID: PMC8176665; PMID: 34086061
Sinha S, Doble M, Manju SL. 5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach. Bioorg Med Chem. 2019;27(17):3745-59. DOI: 10.1016/j.bmc.2019.06.040; PMID: 31331653
Mashima R, Okuyama T. The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox Biol. 2015;6:297–310. DOI: 10.1016/j.redox.2015.08.006; PMCID: PMC4556770; PMID: 26298204
Giménez-Bastida JA, González-Sarrías A, Laparra-Llopis JM, Schneider C, Espín JC. Targeting Mammalian 5-Lipoxygenase by Dietary Phenolics as an Anti-Inflammatory Mechanism: A Systematic Review. Int J Mol Sci. 2021;22(15):7937. DOI: 10.3390/ijms22157937; PMCID: PMC8348464; PMID: 34360703
Wisastra R, Dekker FJ. Inflammation, Cancer and Oxidative Lipoxygenase Activity are Intimately Linked. Cancers. 2014;6(3):1500-21. DOI: 10.3390/cancers6031500; PMCID: PMC4190552; PMID: 25037020
Duroudier NP, Tulah AS, Sayers I. Leukotriene pathway genetics and pharmacogenetics in allergy. Allergy. 2009;64(6):823–39. DOI: 10.1111/j.1398-9995.2009.02015.x; PMID: 19416143
Poeckel D, Funk CD. The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease. Cardiovasc Res. 2010;86(2):243–53. DOI: 10.1093/cvr/cvq016; PMID: 20093252
Rossi A, Pergola C, Koerberle A, Hoffmann M, Dehm F, Bramanti P, et al. The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. Br J Pharmacol. 2010;161(3):555-70. DOI: 10.1111/j.1476-5381.2010.00930.x; PMCID: PMC2990155; PMID: 20880396
Sharanya CS, Abhithaj J, Arun KG, Eeda KR, Bhat V, Variyar EJ, et al. Lipoxygenase inhibitory synthetic derivatives of methyl gallate regulate gene expressions of COX-2 and cytokines to reduce animal model arthritis. Sci Rep. 2023;13(1):10644. DOI: 10.1038/s41598-023-37613-z; PMCID: PMC10313808; PMID: 37391468
Schneider I, Bucar F. Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase[sol ]cyclooxygenase. Phytother Res. 2005;19(2):81–102. DOI: 10.1002/ptr.1603; PMID: 15852496
Perrois C, Strickler SR, Mathieu G, Lepelley M, Bedon L, Michaux S, et al. Differential regulation of caffeine metabolism in Coffeaarabica (Arabica) and Coffea canephora (Robusta). Planta. 2015;241(1):179–91. DOI: 10.1007/s00425-014-2170-7; PMCID: PMC4282694; PMID: 25249475
Bresciani L, Calani L, Bruni R, Brighenti F, Rio DD. Phenolic composition, caffeine content and antioxidant capacity of coffee silverskin. Food Res Int. 2014;61:196–201. DOI: 10.1016/j.foodres.2013.10.047
Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012;366(20):1891–904. DOI: 10.1056/nejmoa1112010; PMCID: PMC3439152; PMID: 22591295
Złotek U, Karaś M, Gawlik-Dziki U, Szymanowska U, Baraniak B, Jakubczyk A. Antioxidant activity of the aqueous and methanolic extracts of coffee beans (Coffea arabica L.). Acta Sci Pol Technol Aliment. 2016;15(3):281–8. DOI: 10.17306/j.afs.2016.3.27; PMID: 28071027
Welsh EJ, Bara A, Barley E, Cates CJ. Caffeine for asthma. Cochrane Database Syst Rev. 2010;2010(1):CD001112. DOI: 10.1002/14651858.cd001112.pub2; PMCID: PMC7053252; PMID: 20091514
Jung S, Kim MH, Park JH, Jeong Y, Ko KS. Cellular Antioxidant and Anti-Inflammatory Effects of Coffee Extracts with Different Roasting Levels. J Med Food. 2017;20(6):626–35. DOI: 10.1089/jmf.2017.3935; PMID: 28581877
Ikan R. Natural Products: A Laboratory Guide. Cambridge (US): Academic Press; 1991.
Irfanah L, Yuwono M, Primaharinastiti R. Optimization and Prevalidation of TLC-Densitometry Method for Fucoidan Analysis in Sargassum sp. Aqueous Extract. J Farmasi Ilmu Kefarmasian Indones. 2023;10(2):210-6. DOI: 10.20473/jfiki.v10i22023.210-216
Young JCOC. True Melting Point Determination. Chem Educator. 2013;18:203-8. DOI: 10.1333/s00897132500a
Subardini DS, Elya B, Noviani A. Lipoxygenase inhibitory assay of ethyl acetate fraction from star fruit leaves (Averrhoa Carambola L.) from three regions in West Java. Int J Appl Pharm. 2020;12(Special 1):119-21. DOI: 10.22159/ijap.2020.v12s1.FF025
Nabilah, Elya B, Djajadisastra J. Lipoxygenase inhibitory assay of Averrhoa carambola L. Leaves extract. Int J ChemTech Res. 2017;10(1):342–7.
Alaba CSM, Chichioco-Hernandez CL. 15-Lipoxygenase inhibition of Commelina benghalensis, Tradescantia fluminensis, Tradescantia zebrina. Asian Pac J Trop Biomed. 2014;4(3):184–8. DOI: 10.1016/s2221-1691(14)60229-x; PMCID: PMC3868787; PMID: 25182435
Patay ÉB, Bencsik T, Papp N. Phytochemical overview and medicinal importance of Coffea species from the past until now. Asian Pac J Trop Med. 2016;9(12):1127–35. DOI: 10.1016/j.apjtm.2016.11.008; PMID: 27955739
Monteiro JP, Alves MG, Oliveira PF, Silva BM. Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks. Molecules. 2016;21(8):974. DOI: 10.3390/molecules21080974; PMCID: PMC6273298; PMID: 27472311
Park JB, Peters R, Novotny JA. Impact of roasting on javamide-I/-II in Arabica and Robusta coffee beans. Food Chem. 2023;412:135586. DOI: 10.1016/j.foodchem.2023.135586; PMID: 36739725
Ky CL, Louarn J, Dussert S, Guyot B, Hamon S, Noirot M. Caffeine, trigonelline, chlorogenic acids and sucrose diversity in wild Coffea arabica L. and C. canephora P. accessions. Food Chem. 2001;75(2):223–30. DOI: 10.1016/s0308-8146(01)00204-7
Gawlik-Dziki U, Świeca M, Dziki D, Kowalska I, Pecio Ł, Durak A, et al. Lipoxygenase inhibitors and antioxidants from green coffee—mechanism of action in the light of potential bioaccessibility. Food Res Int. 2014;61:48–55. DOI: 10.1016/j.foodres.2014.05.002
Tomy MJ, Dileep K V, Prasanth S, Preethidan DS, Sabu A, Sadasivan C, et al. Cuminaldehyde as a lipoxygenase inhibitor: in vitro and in silico validation. Appl Biochem Biotechnol. 2014;174(1):388–97. DOI: 10.1007/s12010-014-1066-0; PMID: 25080377
Purkiewicz A, Pietrzak-Fiećko R, Sörgel F, Kinzig M. Caffeine, Paraxanthine, Theophylline, and Theobromine Content in Human Milk. Nutrients. 2022;14(11):2196. DOI: 10.3390/nu14112196; PMCID: PMC9182860; PMID: 35683994
Oñatibia-Astibia A, Martínez-Pinilla E, Franco R. The potential of methylxanthine-based therapies in pediatric respiratory tract diseases. Respir Med. 2016;112:1–9. DOI: 10.1016/j.rmed.2016.01.022; PMID: 26880379
Kitzberger CSG, Scholz MB dos S, Benassi M de T. Bioactive compounds content in roasted coffee from traditional and modern Coffea arabica cultivars grown under the same edapho-climatic conditions. Food Res Int. 2014;61:61–6. DOI: 10.1016/j.foodres.2014.04.031
Carter GW, Young PR, Albert DH, Bouska J, Dyer R, Bell RL, et al. 5-lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther. 1991;256(3):929–37. PMID: 1848634
Picone S, Bedetta M, Paolillo P. Caffeine citrate: when and for how long. A literature review. J Matern Fetal Neonatal Med. 2012;25(Suppl 3):11–4. DOI: 10.3109/14767058.2012.712305; PMID: 23016611
Aranda JV, Turmen T. Methylxanthines in apnea of prematurity. Clin Perinatol. 1979;6(1):87–108. PMID: 383366
Mukhtar I, Iftikhar A, Imran M, Ijaz MU, Irfan S, Anwar H. The Competitive Absorption by the Gut Microbiome Suggests the First-Order Absorption Kinetics of Caffeine. Dose Response. 2021;19(3):15593258211033111. DOI: 10.1177/15593258211033111; PMCID: PMC8375357; PMID: 34421438
Lu W, Zhao X, Xu Z, Dong N, Zou S, Shen X, et al. Development of a new colorimetric assay for lipoxygenase activity. Anal Biochem. 2013;441(2):162–8. DOI: 10.1016/j.ab.2013.06.007; PMID: 23811155
Published
Issue
Section
Categories
License
Copyright (c) 2024 Tegar Achsendo Yuniarta, Rosita Handayani
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors continue to retain the copyright to the article if the article is published in the Borneo Journal of Pharmacy. They will also retain the publishing rights to the article without any restrictions.
Authors who publish in this journal agree to the following terms:
- Any article on the copyright is retained by the author(s).
- The author grants the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share work with an acknowledgment of the work authors and initial publications in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of published articles (e.g., post-institutional repository) or publish them in a book, with acknowledgment of their initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their websites) prior to and during the submission process. This can lead to productive exchanges and earlier and greater citations of published work.
- The article and any associated published material are distributed under the Creative Commons Attribution-ShareAlike 4.0 International License.